LAVA Therapeutics N.V. (LVTX) Misses Q2 EPS by 2c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q2 EPS of ($0.32), $0.02 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• AppLovin Corp (APP) PT Lowered to $510 at Evercore ISI, 'Taking a More Cautious Q4/FY27 View'
• KBR wins $1.1 billion NOAA weather data contract for five years
• ChargePoint names John Saffrett as Europe EVP and managing director